These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26052977)

  • 21. Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers.
    Lee HY; Jeong JY; Lee KS; Kim HJ; Han J; Kim BT; Kim J; Shim YM; Kim JH; Song I
    Radiology; 2012 Sep; 264(3):884-93. PubMed ID: 22829686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer Vision Tool and Technician as First Reader of Lung Cancer Screening CT Scans.
    Ritchie AJ; Sanghera C; Jacobs C; Zhang W; Mayo J; Schmidt H; Gingras M; Pasian S; Stewart L; Tsai S; Manos D; Seely JM; Burrowes P; Bhatia R; Atkar-Khattra S; van Ginneken B; Tammemagi M; Tsao MS; Lam S;
    J Thorac Oncol; 2016 May; 11(5):709-717. PubMed ID: 26994641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.
    Horeweg N; van der Aalst CM; Thunnissen E; Nackaerts K; Weenink C; Groen HJ; Lammers JW; Aerts JG; Scholten ET; van Rosmalen J; Mali W; Oudkerk M; de Koning HJ
    Am J Respir Crit Care Med; 2013 Apr; 187(8):848-54. PubMed ID: 23348977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doubling times and CT screen–detected lung cancers in the Pittsburgh Lung Screening Study.
    Wilson DO; Ryan A; Fuhrman C; Schuchert M; Shapiro S; Siegfried JM; Weissfeld J
    Am J Respir Crit Care Med; 2012 Jan; 185(1):85-9. PubMed ID: 21997335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
    Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
    Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting adenocarcinoma recurrence using computational texture models of nodule components in lung CT.
    Depeursinge A; Yanagawa M; Leung AN; Rubin DL
    Med Phys; 2015 Apr; 42(4):2054-63. PubMed ID: 25832095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study.
    Walter JE; Heuvelmans MA; Bock GH; Yousaf-Khan U; Groen HJM; Aalst CMV; Nackaerts K; Ooijen PMAV; Koning HJ; Vliegenthart R; Oudkerk M
    Thorax; 2018 Aug; 73(8):741-747. PubMed ID: 29661918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Density features of screened lung tumors in low-dose computed tomography.
    Shen WC; Liu JC; Shieh SH; Yang ST; Tseng GC; Hsu WH; Chen CY; Yu YH
    Acad Radiol; 2014 Jan; 21(1):41-51. PubMed ID: 24331263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The rationale for, and design of, a lung cancer screening program.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Iterative Reconstruction Algorithms on Computer-assisted Detection (CAD) Software for Lung Nodules in Ultra-low-dose CT for Lung Cancer Screening.
    Nomura Y; Higaki T; Fujita M; Miki S; Awaya Y; Nakanishi T; Yoshikawa T; Hayashi N; Awai K
    Acad Radiol; 2017 Feb; 24(2):124-130. PubMed ID: 27986507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort.
    Greenberg AK; Lu F; Goldberg JD; Eylers E; Tsay JC; Yie TA; Naidich D; McGuinness G; Pass H; Tchou-Wong KM; Addrizzo-Harris D; Chachoua A; Crawford B; Rom WN
    PLoS One; 2012; 7(7):e39403. PubMed ID: 22768300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline and annual repeat rounds of screening: implications for optimal regimens of screening.
    Henschke CI; Salvatore M; Cham M; Powell CA; DiFabrizio L; Flores R; Kaufman A; Eber C; Yip R; Yankelevitz DF;
    Eur Radiol; 2018 Mar; 28(3):1085-1094. PubMed ID: 28983713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
    Veronesi G; Bellomi M; Mulshine JL; Pelosi G; Scanagatta P; Paganelli G; Maisonneuve P; Preda L; Leo F; Bertolotti R; Solli P; Spaggiari L
    Lung Cancer; 2008 Sep; 61(3):340-9. PubMed ID: 18308420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of CT screening for lung cancer in never-smokers: analysis of Japanese cases detected using a low-dose CT screen.
    Kondo R; Yoshida K; Kawakami S; Shiina T; Kurai M; Takasuna K; Yamamoto H; Koizumi T; Honda T; Kubo K
    Lung Cancer; 2011 Dec; 74(3):426-32. PubMed ID: 21663997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Analysis of Clinical Characteristics and Prognosis Between Primary Lung Cancers Identified as Screening Detected and Incidentally Detected Pulmonary Nodules.
    Zo S; Kim C; Lee HY; Park G; Shin SH; Jeong BH; Lee K; Kim H; Kim HK; Um SW
    Anticancer Res; 2024 Jul; 44(7):3163-3173. PubMed ID: 38925826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung Cancer Risk Associated With New Solid Nodules in the National Lung Screening Trial.
    Pinsky PF; Gierada DS; Nath PH; Munden R
    AJR Am J Roentgenol; 2017 Nov; 209(5):1009-1014. PubMed ID: 28898131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic performance of low-dose computed tomography screening for lung cancer over five years.
    Veronesi G; Maisonneuve P; Spaggiari L; Rampinelli C; Pardolesi A; Bertolotti R; Filippi N; Bellomi M
    J Thorac Oncol; 2014 Jul; 9(7):935-939. PubMed ID: 24922008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters.
    Takahashi M; Shigematsu Y; Ohta M; Tokumasu H; Matsukura T; Hirai T
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):54-9. PubMed ID: 24131786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.